Justin Eyquem

Justin Eyquem is an Assistant Professor at the University of California, San Francisco (UCSF) specializing in cancer immunotherapy and gene editing technologies.1 His research focuses on developing next-generation cell therapies for cancer treatment.2

Expertise and Skills

Justin Eyquem's areas of expertise include:

• Adoptive Immunotherapy
• Chimeric Antigen Receptor (CAR) T-cell therapy
• Genome editing techniques, particularly CRISPR technology1

Professional Achievements

Research Recognition:: Eyquem was recently selected as one of the five Pew-Stewart Scholars, an honor bestowed upon promising early-career scientists in cancer research.3

Public Engagement:: He actively shares insights on next-generation cell therapies, participating in podcasts such as the Parker Institute for Cancer Immunotherapy's "From Bench to Fireside".2

Recent Activities

Justin Eyquem is involved in various research and outreach activities:

• He is working on improving the manufacturing and access of gene-edited primary immune cell therapies.4
• Eyquem participates in fundraising efforts for cancer research, such as the ACRF's 2km a Day in May challenge.3

It's worth noting that while some search results mention a position at the Karolinska Institute, the most recent and relevant information indicates that Justin Eyquem is currently an Assistant Professor at UCSF.1